May 31, 2003

Vaccinations Not Virus Responsible for Spanish Flu

Dr. Mercola

The following is an interesting commentary about an article on the 1918-1920 pandemic, which the propaganda says was caused by Spanish flu (Irish Examiner, May 1. It took a British science team to identify the first virus in man in 1933, yet propaganda says that the virus of Spanish flu killed millions of civilians and soldiers during the pandemic from 1918 to 1920.

Many would have us believe that all those American soldiers who died from non-combatant causes died from Spanish flu.

However, U.S. Army records show that seven men died after being vaccinated. Further, according to a report from U.S. Secretary of War Henry L Stimson, the deaths were not only verified but also there had been 63 deaths and 28,585 cases of hepatitis reported as a direct result of yellow fever vaccination

during only six months of the war. Plus, the yellow fever vaccination was only one of the 14 to 25 shots given to recruits. After vaccination became a requirement in the U.S. Army in 1911, cases of typhoid and vaccinal diseases increased rapidly, according to Army records.

The death rate from typhoid reached the highest point in the history of the U.S. Army after America entered the war in 1917. In 1917, 19,608 men were admitted into army hospitals due to anti-typhoid inoculation and vaccinia, according to a report of the Surgeon-General of the U.S. Army; and this doesn't take into account others whose symptoms were attributed to other causes. The army doctors knew all these cases of disease and death were due to vaccination and were honest enough to admit it in their medical reports.

Army doctors tried to suppress the symptoms of typhoid with a stronger vaccine, however it caused a worse form of typhoid, paratyphoid.

They then concocted an even stronger vaccine to suppress the previous one and created an even worse disease--Spanish flu.

After the war, this was one of the vaccines used to protect a panic-stricken world from the soldiers returning from WWI battlefronts infected with dangerous diseases. The rest is history. Irish May 8, 2003

DR. MERCOLA'S COMMENT: The bottom line here is that vaccines are not the answer. Vaccines, all vaccines, are immune suppressing; that is they depress our immune functions, which leaves us vulnerable to any number of diseases. Vaccines contain many chemicals and heavy metals such as mercury and aluminum, which, aside from being immune system suppressors, can cause serious damage to your body. However, while vaccines help to tear our immunity down, proper nutrition will build and support a strong immune system, which will provide natural immunity against a number of diseases.

May 29, 2003

Soldier Refusing Anthrax Shot Guilty

Associated Press

FORT DRUM, N.Y. - A military panel on Wednesday found an Army reservist guilty of disobeying an order for refusing to take the anthrax vaccine. The panel of eight officers took only 40 minutes before returning a guilty verdict against Pvt. Kamila Iwanowska.

Iwanowska, 26, admitted in a court "stipulation of fact" that she refused to follow the verbal and written orders of her commanding officers. Army prosecutors read a statement to the panel and rested their case without calling any witnesses.

"Good order and discipline and following orders is essential in the United States Army," Capt. Wesley Rowley said in a brief opening statement.

Rowley said Iwanowska's signed statement was all the proof the panel needed for a conviction.

Defense Attorney Capt. Jeremy Ball told panel members what was not in Iwanowska's statement is why she refused, "and that's what this case is ultimately about."

"I ask that you reserve judgments of her and her wrongfulness until you understand more about the why," said Ball, who also rested without calling any witnesses.

Ball said he planned to call Iwanowska and several other witnesses during the sentencing phase, which was to begin later Wednesday.

Iwanowska, of New York City, was charged with disobeying an order to get the anthrax vaccine after reporting for pre-deployment processing with her unit in January. After being brought up on disciplinary charges by her company commander, Iwanowska was twice ordered to take the vaccine by Col. Emory Helton, the garrison commander, but refused.

Iwanowska, who is Polish and became an American citizen last year, told her superiors that she considered the shot medically dangerous to children she might have in the future, saying the long-term effects of the anthrax vaccine are unknown. As a Roman Catholic, she also cited religious reasons for refusing it.

On Tuesday, a military judge had upheld the legality of the vaccination program and refused to dismiss the charge.

The Pentagon insists the vaccination is safe, with severe adverse reactions developing in only about one in 100,000 vaccinations.

May 28, 2003


Red Flags Daily
Nicholas Regush, HEALTH NEWS ANALYZER -#213

This is indeed another sad case of the U.S. military playing with someone's life. An Army reservist refused to take the anthrax shot because she feared it might be medically dangerous to children she might have. So a court-martial convicted her and now she faces hard times and prison. Here's the story.

A lot has already been written about the military's mind-numbing
mishandling of the anthrax vaccine, particularly how the vaccine has neither been properly tested, nor approved for use by the FDA, to protect against inhaled anthrax. It's also unfortunate that media coverage of this issue is so pathetic. The AP report is merely an example of how media can't get this story into focus.

For example, all we get from the story in way of criticism of the vaccine is that the "Pentagon insists the vaccination is safe, with severe adverse reactions developing in about one in 100,000 vaccinations."

That's just a ton of crap.

First of all, that one in 100,000 figure is the product of a useless government reporting system that catches a small fraction of vaccine adverse reactions. Furthermore, there are credible documents available to any reporter, showing how the U.S. military encouraged little or no reporting about anthrax vaccine side-effects and how a central command got into the act in defining which side-effects could be reported. I know all this because of my research on the anthrax vaccine for my
forthcoming book on vaccines.

And not to have at least a couple of paragraphs showing how the U.S. military and the FDA violated basic regulatory rules on the anthrax vaccine is absolutely outlandish because that information is also readily available.

A black eye for journalism, the FDA, and the military. One day, the real story may get out about all this, and some bigwigs hopefully will pay a heavy price for this continuing travesty.

May 27, 2003

Court-martial For NY Soldier Who Refused Anthrax Vaccine

Associated Press

(Fort Drum-AP, May 27, 2003) — Court-martial proceedings are under way for an Army reservist who's charged with disobeying orders to take an anthrax vaccine.
This morning, Private Kamila Iwanowska of New York City asked a military judge at Fort Drum to throw out a charge that she disobeyed orders given by both her company captain and the garrison commander.

Her defense counsel argued that it was the same order and that Iwanowska had already received 48 days confinement from the captain for her refusal.

The defense team also asked for dismissal of the charge, saying federal statutes allow a soldier to refuse a command if it's an unlawful order.

Defense attorney Kenneth Levine says he hoped to prove the order was unlawful because the anthrax vaccine has never been formally approved by the U.S. Food and Drug Administration.

Army officials say Iwanowska refused an anthrax shot at Fort Drum, saying the long-term effects of the anthrax vaccine are unknown.

VaxGen to test anthrax vaccine on people

Associated Press

SAN FRANCISCO - Federal regulators approved VaxGen Inc.'s plan to test its experimental anthrax vaccine on about 100 people, the biotechnology company announced Tuesday.

The Brisbane-based company said it will begin testing the genetically engineered vaccine in a matter of days to produce an emergency stockpile for the nation.

News of the Food and Drug Administration's action was announced after the stock markets closed but it still sent VaxGen's stock soaring in after hours trading. The company's share price gained $2.63, or 79 percent, to $5.97.

The company's stock has plummeted from a 52-week high of $23.25 and has been dropping consistently since it announced in March that its AIDS vaccine experiment was mostly a failure.

The human volunteers will be injected with the experimental anthrax vaccine to see if it's safe and produces the desired immune response. No volunteer will be exposed to anthrax itself but rabbits and monkeys will be used at Battelle Memorial Institute in Columbus, Ohio.

The human and animal data will be presented to together to the FDA in hopes of winning the agency's approval.

VaxGen was awarded a $13.6 million federal contract to begin work on the vaccine and is applying for two more anthrax vaccine contracts expected to be awarded later this year for advanced testing and manufacturing of 25 million doses.

'War vaccines poisoned us'

By Rebecca Mowling, Evening Standard

Four British soldiers who received jabs for the Iraq conflict are to sue the Ministry of Defence claiming they are suffering from a new form of Gulf War Syndrome. The revelation comes as a veterans' support group predicted today that thousands of UK servicemen will come forward with mystery illnesses linked to "vaccine overload".

Tony Flint of the National Gulf Veterans and Families' Association, confirmed he now anticipates a fresh wave of health cases. "We are expecting at least 6,000 new cases as a result of the Iraq conflict - about 30 per cent of the 22,000 troops who had the anthrax vaccination."

The first four soldiers from the latest conflict who are set to sue - two reservists and two regulars - are blaming depression, breathing problems and eczema on injections they were given before being sent to the Middle East.

Professor Malcolm Hooper, chief scientific adviser to the veterans' association, said the MoD did not seem to have learned from "the mistakes of the 1991 conflict" in relation to multiple vaccinations. "These guys are clearly suffering from vaccine overload," he said.

The key concern centres on soldiers given anthrax vaccines on top of other more routine inoculations.

Professor Hooper added: "The problem was one which was there in 1991. Our studies have shown that these people have excessive symptoms - three to four-fold compared with people who have not been vaccinated in the same way."

Concern about the long-term side-effects led to almost half the 45,000 British servicemen and women in the recent conf lict refusing vaccinations against anthrax, fearing that they might be afflicted by the syndrome. However, all four men are understood to have been given the anthrax vaccination and had multiple jabs in one day before falling ill.

Royal Engineers reservist Stephen Cartwright was taken to hospital with a fever and blistered skin after being given a number of jabs, including the controversial anthrax vaccine. The 24-yearold spent four days in hospital and was so ill he did not make it to the Gulf.

The second reservist, Tony Barker, 45, was given five vaccinations - hepatitis, typhoid, polio, diphtheria and yellow fever on 17 February, days after he was called up. The father-of-one received an anthrax jab less than a week later. The Royal Logistics Corps driver fell ill in Kuwait after being given nerve agent pre-treatment and anti-malarial pills. He also had a second anthrax jab on 13 March.

Lawyer Mark McGhee, who is acting for the four men, said: "The symptoms that these four individuals are experiencing are identical to those of the individuals I represent in relation to the first Gulf war." The High Court is due to rule within weeks on whether Gulf War Syndrome can be recognised in law.

But the MoD has also accepted that some troops returning from the latest conflict may suffer long-term health problems as a result of the war and has begun a screening programme.

Medical experts renew call to freeze smallpox vaccinations

By Matthew Weinstock

An ambitious smallpox vaccination program should be put on hold before it is expanded to a large pool of emergency responders, the influential Institute of Medicine said Tuesday.

Right now, the program is still in its so-called phase one, principally dedicated to nurses and doctors. Phase two, which states are expected to roll out this summer, includes first responders, such as firefighters, police officers and other emergency personnel.

In its ongoing review of the national smallpox vaccination program, the Institute of Medicine, a branch of the National Academy of Sciences that advises the government on health care policy, said the pause is necessary to consider changes to the strategy.

The Bush administration launched the program in January. It was the first time in 30 years that the vaccine was administered in the United States. The World Health Organization officially declared the disease eradicated in 1980. But fear of a bioterrorism attack led administration officials to revive the vaccination program.

The strategy calls for voluntary armies of smallpox response teams in every state. These would consist of nurses, doctors and emergency responders inoculated against the disease. They could sweep into areas of an outbreak and administer the vaccine.

As many as 450,000 health care workers have been identified as potential participants in the first phase of the program. Another 10 million workers could be included in the second phase. To date, 36,000 health care workers have been vaccinated. Administration officials had wanted to have roughly 50,000 health care workers vaccinated by now.

Between January and early May, more than 40 cases of side effects among vaccinated workers, including inflamed hearts, were reported to the Centers for Disease Control and Prevention. Three people have died. It is unclear if there is a direct link to the vaccine. The IOM wants the CDC to get a better handle on the medical complications before offering the vaccine to a broader universe of health care workers.

In addition, the IOM, in a May 23 letter to CDC Director Julie Gerberding, said it is "imperative" that national and state public health officials determine the number of people they need vaccinated. Health and Human Services officials have consistently said that they do not have a set target. Rather, they are leaving it up to the states to come up with their own goals.

"We are not pausing the program," Jerome Hauer, head of public health preparedness at the Health and Human Services Department said during an interview Friday. "The IOM has its opinions. We certainly understand that. It doesn't mean that we follow them. [Secretary Tommy Thompson] has a host of experts and there is no pause ... if health departments want to vaccinate police and firemen, they are free to do that."

The IOM recognizes that a pause comes with some risks.

"A pause implies slower vaccination of the number of responders a jurisdiction may require for preparedness, a loss of momentum, and perhaps vulnerability in the event of a potential smallpox event," the group's letter said. "However, given that the smallpox threat level, as it is publicly described, has not changed, the committee continues to believe that the benefits of the pause likely outweigh the risks. The committee is aware that some jurisdictions have already begun offering the vaccine to a wider population of potential vaccinees, but reaffirms the need for a pause."

May 1, 2003

Influenza vaccination and Guillain Barre syndrome

Influenza vaccination and Guillain Barre syndrome small star, filled.
Geier MR, Geier DA, Zahalsky AC.
The Genetic Centers of America, 14 Redgate Court, 20905, Silver Spring,MD, USA

Acute and severe Guillain Barre Syndrome (GBS) cases reported following influenza vaccine to the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1999 were examined. Endotoxin concentrations were measured using the Limulus amebocyte lysate assay in influenza vaccines.

There were a total of 382 cases of GBS reported to the VAERS database following
influenza vaccination (male/female ratio, 1.2). The median onset of GBS following influenza vaccine was 12 days (interquartile range, 7 days to 21 days).

There was an increased risk of acute GBS (relative risk, 4.3; 95% confidence interval, 3.0 to 6.4) and severe GBS (relative risk, 8.5; 95% confidence interval, 3.7 to 18.9) in comparison to an adult tetanus-diphtheria (Td) vaccine control group.

There were maximums in the incidence of GBS following influenza vaccine that occurred approximately every third year (1993, 1996, and 1998) and statistically significant variation in the incidence of GBS among different influenza manufacturers. Influenza vaccines contained from a 125- to a 1250-fold increase in endotoxin concentrations in comparison to an adult Td vaccine control and endotoxin concentrations varied up to 10-fold among different lots and manufacturers of influenza vaccine.

The biologic mechanism for GBS following influenza vaccine may involve the synergistic effects of endotoxin and vaccine-induced autoimmunity. There were minimal potential reporting biases in the data reported to the VAERS database in this

Patients should make an informed consent decision on whether to take this optional vaccine based upon its safety and efficacy and physicians should vigilantly report GBS following influenza vaccination to the VAERS in the United States so that continued evaluation of the safety of influenza vaccine may be undertaken.